Neurocrine Biosciences: Q1 Earnings Insights

Neurocrine Biosciences NBIX reported its Q1 earnings results on Wednesday, May 4, 2022 at 07:30 AM.

Here's what investors need to know about the announcement.

Earnings

Neurocrine Biosciences missed estimated earnings by 11.76%, reporting an EPS of $0.3 versus an estimate of $0.34.

Revenue was up $74.00 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.48 which was followed by a 7.45% increase in the share price the next day.

Here's a look at Neurocrine Biosciences's past performance:

To track all earnings releases for Neurocrine Biosciences visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.